#News for #Media: The movement continues with the launch of Risk to Reasons UK – two new guides created for women and healthcare professionals that encourage open and positive conversations about #HIV prevention. https://t.co/wfO5zPdpoK #RiskToReasons #HIVPrevention

#News for #Investors and #Media: The National Institute for Health and Care Excellence (NICE) has recommended our HIV prevention regimen for use in England & Wales. For investors and media https://t.co/044AnhqU6K.

#News for #Investors and #Media: Data presented at #EACS2025 compare the tolerability and acceptability of innovative HIV medicines. Find out more 👉 https://t.co/044AnhqU6K

We're at a pivotal moment in the quest to end #HIV. Learn more about the transformational science fuelling our research in this @newscientist article with Jean van Wyk, Babafemi Taiwo, Sherene Min, and Annemiek de Ruiter: https://t.co/iVtV1f3ysj

#News for #Investors #Media We’ll be at #EACS2025 & #IDWeek2025, showcasing our innovation & real-world evidence from our #HIV treatment and prevention portfolio. Learn more: https://t.co/Y6CRbVUpBV

For some people living with #HIV, self-stigma is one of many challenges in managing their health. But HIV care is evolving. Prof. Antonella Castagna shares how personal choice and tailored options are reshaping HIV care. 👉Read the ViiV sponsored article: https://t.co/pgl6LmIvc7

INSTIs are recommended in many first-line #HIV regimens for their potency, long-term tolerability, and high barrier to resistance. Hear more: https://t.co/n44TG7QZHD #WeWontStop

We’re exploring how broadly neutralising antibodies (bNAbs) can target and eliminate hidden #HIV reservoirs. Our Induce and Reduce strategy focuses on using bNAbs to drive the reservoir out of hiding, so it can be eliminated. Explore the research: https://t.co/MFW7rs0206

Innovation is giving people control of their #HIV care 🙌 We’ve partnered with @CNNCreate to tell the story about the real impact scientific innovation has on people’s lives. Learn more 👉 https://t.co/HsVvO4wztt Content by ViiV Healthcare

Innovation is giving people control of their #HIV care, with therapies that offer people options for how and when they take medicine. Find out more about our partnership with @CNNCreate Learn more 👉 https://t.co/IYnyErHF8G Content by ViiV Healthcare

We’re feeling energised after an action-packed week at #IAS2025 in Kigali, Rwanda. Check out our highlights 👇🎥 #WeWontStop @iasociety

#WeWontStop until we make HIV history 🤝 The message from #IAS2025 was clear – innovation, people and partnership will help us end the #HIV epidemic. Learn more from Shaun Mellors and some of our partners ☝️🎥

At #IAS2025 we presented interim data from our Positive Perspectives 3 (PP3) study, which, once complete, will be one of the largest surveys of people living with #HIV, including more than 3000 participants across 29 countries.   Find out more 👇   #WeWontStop

Yesterday at #IAS2025, we asked: What will it take to make HIV history? Our symposium ignited a passionate debate, with experts and the audience weighing in on the role we all play in getting closer to ending the #HIV epidemic through people, partnership and innovation.

🎥 Reporting live from #IAS2025 in Kigali, Rwanda! Join Doreen as she takes a tour of our booth and meets some of the ViiV team.   Our booth at IAS reinforces our commitment to developing the next generation of medicines to help end #HIV for everyone.   #WeWontStop #IAS2025

Today at #IAS2025, @WHO updated their guidelines, which show that despite uncertainty, we’re continuing to prioritise the #HIV response with new innovations that can enable more choice for people living with and impacted by HIV. Learn more from Helen McDowell 👇📹 #WeWontStop

#News for #Investors and #Media: Data presented at #IAS2025 reinforce the importance of providing people living with #HIV with innovative treatment options that best suit their individual needs and preferences. Find out more 👉 https://t.co/044AnhqU6K

#News for #Investors and #Media: We've expanded our voluntary license with the Medicines Patent Pool to include further innovative treatments alongside prevention to enable increased access and reach those most impacted by #HIV. Find out more 👉 https://t.co/044AnhqU6K

What do you get when you pair 22 scientists with 22 fashion designers? The answer… the coolest lab coats you’ve ever seen 🧪🥼 The #HIVUnwrapped exhibition has launched at #IAS2025 - a powerful partnership between science and community 🤝 #WeWontStop

Reporting live from #IAS2025 in Kigali, Rwanda   First up, watch Doreen Moracha talk to Dr Babafemi Taiwo, our VP of early development, on the importance of pioneering transformational medicines that can give people living with – and impacted by – HIV more choice.   #WeWontStop